Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

NATerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Thyroid Cancer
Interventions
RADIATION

Radioactive Iodine 124

"After TSH stimulation with Recombinant human TSH (rhTSH) for 2 days, a dose of radioactive iodine 124 ( I-124) 1.7 mCi is administrated orally and PET imaging is done for 5 continuous days including the day of the dose administration. On each day, just before imaging, 5 ml of blood is drawn.~Patients will be randomized to either the sequence above (e.g. I-131 followed by I-124) or to the reverse sequence in which the I-124 is given first followed by the I-131. If I-124 is administered first and as long as the whole body retention is \< 2% by the start of the second rhTSH stimulation, the I-124 will not interfere with the I-131."

Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

All Listed Sponsors
lead

Medstar Health Research Institute

OTHER